These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8043014)

  • 1. Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase.
    Muskardin DT; Voelkel NF; Fitzpatrick FA
    Biochem Pharmacol; 1994 Jul; 48(1):131-7. PubMed ID: 8043014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.
    Orning L; Krivi G; Fitzpatrick FA
    J Biol Chem; 1991 Jan; 266(3):1375-8. PubMed ID: 1846352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification.
    Amann R; Schuligoi R; Peskar BA
    Inflamm Res; 1999 Dec; 48(12):632-6. PubMed ID: 10669114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
    Baker JR; Kylstra TA; Bigby TD
    Biochem Pharmacol; 1995 Sep; 50(7):905-12. PubMed ID: 7575672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4 hydrolase.
    Evans JF; Kargman S
    FEBS Lett; 1992 Feb; 297(1-2):139-42. PubMed ID: 1312948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung.
    Brock TG; Lee YJ; Maydanski E; Marburger TL; Luo M; Paine R; Peters-Golden M
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L224-32. PubMed ID: 15805137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
    Schulz R; Seeger W
    Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs.
    Grimminger F; Becker G; Seeger W
    J Immunol; 1988 Oct; 141(7):2431-6. PubMed ID: 2844900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
    Byrum RS; Goulet JL; Snouwaert JN; Griffiths RJ; Koller BH
    J Immunol; 1999 Dec; 163(12):6810-9. PubMed ID: 10586081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.
    Nathaniel DJ; Evans JF; Leblanc Y; Léveillé C; Fitzsimmons BJ; Ford-Hutchinson AW
    Biochem Biophys Res Commun; 1985 Sep; 131(2):827-35. PubMed ID: 2996528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of leukotriene production following sequestration of neutrophils in isolated lungs: indirect evidence for intercellular leukotriene A4 transfer.
    Grimminger F; Menger M; Becker G; Seeger W
    Blood; 1988 Nov; 72(5):1687-92. PubMed ID: 2846088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of leukotriene biosynthetic capacity in lung tissues from horses with recurrent airway obstruction.
    Lindberg A; Näsman-Glaser B; Lindgren JA; Robinson NE
    Am J Vet Res; 2002 Jun; 63(6):794-8. PubMed ID: 12061522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of leukotriene A4 epoxide hydrolase from dog lung.
    Manganaro F; Gaudette Y; Pombo-Gentile A; Singh K; Rakhit S
    Prostaglandins; 1988 Dec; 36(6):859-74. PubMed ID: 2854285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
    Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
    Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and metabolism of leukotrienes by human endothelial cells: influence on prostacyclin release.
    Ibe BO; Campbell WB
    Biochim Biophys Acta; 1988 Jun; 960(3):309-21. PubMed ID: 2838089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymes functional in the syntheses of leukotrienes and related compounds.
    Shimizu T
    Int J Biochem; 1988; 20(7):661-6. PubMed ID: 2846379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
    Honda Z; Iizasa T; Morita Y; Matsuta K; Nishida Y; Miyamoto T
    Biochem Pharmacol; 1987 May; 36(9):1475-81. PubMed ID: 3034290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.
    Mueller MJ; Wetterholm A; Blomster M; Jörnvall H; Samuelsson B; Haeggström JZ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8383-7. PubMed ID: 7667299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
    Davidson D; Drafta D
    J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.